Startseite lx arp1

CAMKIIγ is a targetable driver of multiple myeloma through CaMKIIγ

Von einem Mystery-Man-Autor
Last updated 28 mai 2024
CAMKIIγ is a targetable driver of multiple myeloma through CaMKIIγ
CAMKIIγ is a targetable driver of multiple myeloma through CaMKIIγ
Overexpression of CAMKIIγ was associated with disease progression
CAMKIIγ is a targetable driver of multiple myeloma through CaMKIIγ
PDF) Targeting MYC and BCL2 by a Natural Compound for “Double‐Hit
CAMKIIγ is a targetable driver of multiple myeloma through CaMKIIγ
Alternative approaches to target Myc for cancer treatment
CAMKIIγ is a targetable driver of multiple myeloma through CaMKIIγ
Pharmaceutics, Free Full-Text
CAMKIIγ is a targetable driver of multiple myeloma through CaMKIIγ
In vitro and in vivo efficacy of the novel oral proteasome
CAMKIIγ is a targetable driver of multiple myeloma through CaMKIIγ
Frontiers Deregulated calcium signaling in blood cancer
CAMKIIγ is a targetable driver of multiple myeloma through CaMKIIγ
Heme oxygenase-1 inhibition mediates Gas6 to enhance bortezomib
CAMKIIγ is a targetable driver of multiple myeloma through CaMKIIγ
Heme oxygenase-1 inhibition mediates Gas6 to enhance bortezomib
CAMKIIγ is a targetable driver of multiple myeloma through CaMKIIγ
PDF] CAMKIIγ is a targetable driver of multiple myeloma through
für dich empfohlen
Sie können auch mögen

© 2014-2024 esfamim.com. Inc. or its affiliates.